Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab
Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab
Recruiting · NCT07006532 · Registry updated 2026-02-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab | Kidney Transplant Rejection | Recruiting | Not applicable | 2026-02-11 | NCT07006532 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shahid Beheshti University of Medical Sciences | 18 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Nooshin Dalili | Tehran | Iran | 3 |